Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SLRX

SLRX News

Newswire

08:02

Salarius Pharmaceuticals Partners with Texas Biomedical Research Institute on Avian Flu Study

16:47

Salarius Pharmaceuticals' CFO Rosenblum Mark J buys 20,000 shares at $0.8/share on 11/20/2025.

14:45

Salarius Pharmaceuticals Addresses Errors on S&P CapIQ Platform, Affirms Nasdaq Listing Under 'SLRX' Symbol

09:55

Ewing Sarcoma Market Poised for Growth: Salarius, Eli Lilly, Pfizer, and BioAtla Drive Innovation with Novel Targeted Therapies

20:39

Salarius Pharmaceuticals Clarifies Nasdaq Listing Status

View More

About SLRX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More